Instil Bio (TIL) Other Working Capital Changes (2020 - 2026)
Instil Bio (TIL) posted Other Working Capital Changes of $162000.0 for Q2 2026, up 110.62% on a QoQ basis from -$1.5 million in Q1 2026, and down 75.15% year-over-year from $652000.0 in Q2 2025.
Analysis
Instil Bio (TIL) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Instil Bio has reported Other Working Capital Changes for 7 years, with the latest figure at $162000.0 in Q2 2026.
- On a quarterly basis, Other Working Capital Changes fell 75.15% year-over-year to $162000.0 in Q2 2026; TTM through Jun 2026 was -$1.6 million, a 64.94% increase from a year earlier, with the FY2025 full-year figure at -$6.1 million, down 344.08% from the prior year.
- Other Working Capital Changes was $162000.0 for Q2 2026 at Instil Bio, up from -$1.5 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $5.0 million in Q3 2024, with the low at -$6.5 million in Q1 2025.
- Average Other Working Capital Changes over 5 years is -$479555.6, with a median of -$373000.0 recorded in 2022.
- The largest YoY upside for Other Working Capital Changes was 437.92% in 2022 against a maximum downside of 2564.65% in 2022.
- Over 5 years, Other Working Capital Changes stood at -$540000.0 in 2022, then soared by 61.85% to -$206000.0 in 2023, then slumped by 1801.46% to -$3.9 million in 2024, then surged by 69.82% to -$1.2 million in 2025, then jumped by 113.71% to $162000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $162000.0 (Q2 2026), -$1.5 million (Q1 2026), and -$1.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Instil Bio | 50.19 Mn | 50.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 162,000.00 |
| Jun 30, 2026 | 162,000.00 |
| Mar 31, 2026 | -1.53 Mn |
| Mar 31, 2026 | -1.53 Mn |
| Dec 31, 2025 | -1.18 Mn |
| Dec 31, 2025 | -1.18 Mn |
| Sep 30, 2025 | 897,000.00 |
| Sep 30, 2025 | 897,000.00 |
| Jun 30, 2025 | 652,000.00 |
| Jun 30, 2025 | 652,000.00 |
| Mar 31, 2025 | -6.48 Mn |
| Mar 31, 2025 | -6.48 Mn |
| Dec 31, 2024 | -3.92 Mn |
| Dec 31, 2024 | -3.92 Mn |
| Sep 30, 2024 | 5.04 Mn |
| Sep 30, 2024 | 5.04 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | -1.34 Mn |
| Mar 31, 2024 | -1.34 Mn |